The emerging class of GLP-1 agonist medication and GIP co-agonist medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, represent significant advances in diabetes treatment https://tirzepatide745245.thehighlifeblog.com/921928/retatrutide-one-thorough-look